Cite
MLA Citation
V. Vorobyev et al.. “P1123: TEMPO: A PHASE 2, RANDOMIZED, OPEN-LABEL, 2-ARM STUDY COMPARING TWO INTERMITTENT DOSING SCHEDULES OF DUVELISIB IN SUBJECTS WITH INDOLENT NON-HODGKIN LYMPHOMA (INHL).” HemaSphere, vol. 6, n.d., pp. 1013–1014. http://access.bl.uk/ark:/81055/vdc_100159756623.0x00000c